Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hanseo Chem is a South Korean fine chemical company specializing in the development and manufacture of high-purity electronic materials and pharmaceutical intermediates. Founded in 1997, the company provides CDMO services for the synthesis of Active Pharmaceutical Ingredients (APIs) and advanced intermediates used in various therapeutic areas, including metabolic and infectious diseases. Their core competencies include complex chemical synthesis, high-vacuum distillation, and scaling up production from laboratory research to commercial volumes. Hanseo Chem operates state-of-the-art manufacturing facilities in South Korea, serving a global clientele in both the pharmaceutical and display technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hanseo Chem.